Stay updated on Inotuzumab Ozogamicin vs Vincristine in B-ALL Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin vs Vincristine in B-ALL Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin vs Vincristine in B-ALL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer now shows a new Revision: v3.3.3 label, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedNew revision entry v3.3.2 has been added and v3.2.0 removed in the Record History, representing a minor version-control update with no changes to study data or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding lapse notice banner at the top of the page has been removed. The study details and record history remain unchanged.SummaryDifference0.6%

- Check71 days agoChange DetectedThe record history includes multiple updates to Study Status (including Recruitment Status) and one update to the Study Description, reflecting changes in trial activity and enrollment.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference11%

- Check107 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Inotuzumab Ozogamicin vs Vincristine in B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin vs Vincristine in B-ALL Clinical Trial page.